182 related articles for article (PubMed ID: 21833796)
21. The rational design of cell-penetrating peptides for application in delivery systems.
Kang Z; Ding G; Meng Z; Meng Q
Peptides; 2019 Nov; 121():170149. PubMed ID: 31491454
[TBL] [Abstract][Full Text] [Related]
22. Delivery of cell membrane impermeable peptides into living cells by using head-to-tail cyclized mitochondria-penetrating peptides.
Yang QQ; Zhu LJ; Xi TK; Zhu HY; Chen XX; Wu M; Sun C; Xu C; Fang GM; Meng X
Org Biomol Chem; 2019 Dec; 17(45):9693-9697. PubMed ID: 31691700
[TBL] [Abstract][Full Text] [Related]
23. Zwitterionic guanidine-based oligomers mimicking cell-penetrating peptides as a nontoxic alternative to cationic polymers to enhance the cellular uptake of micelles.
Kim Y; Binauld S; Stenzel MH
Biomacromolecules; 2012 Oct; 13(10):3418-26. PubMed ID: 22946476
[TBL] [Abstract][Full Text] [Related]
24. Mitochondria-targeted drug delivery system for cancer treatment.
Chen ZP; Li M; Zhang LJ; He JY; Wu L; Xiao YY; Duan JA; Cai T; Li WD
J Drug Target; 2016; 24(6):492-502. PubMed ID: 26548930
[TBL] [Abstract][Full Text] [Related]
25. Classes of Cell-Penetrating Peptides.
Pooga M; Langel Ü
Methods Mol Biol; 2015; 1324():3-28. PubMed ID: 26202259
[TBL] [Abstract][Full Text] [Related]
26. Identification of Short Hydrophobic Cell-Penetrating Peptides for Cytosolic Peptide Delivery by Rational Design.
Schmidt S; Adjobo-Hermans MJ; Kohze R; Enderle T; Brock R; Milletti F
Bioconjug Chem; 2017 Feb; 28(2):382-389. PubMed ID: 27966361
[TBL] [Abstract][Full Text] [Related]
27. Hydrophobicity drives the cellular uptake of short cationic peptide ligands.
Gupta A; Mandal D; Ahmadibeni Y; Parang K; Bothun G
Eur Biophys J; 2011 Jun; 40(6):727-36. PubMed ID: 21409455
[TBL] [Abstract][Full Text] [Related]
28. Hydrophobic and electrostatic interactions between cell penetrating peptides and plasmid DNA are important for stable non-covalent complexation and intracellular delivery.
Upadhya A; Sangave PC
J Pept Sci; 2016 Oct; 22(10):647-659. PubMed ID: 27723187
[TBL] [Abstract][Full Text] [Related]
29. Interaction of yeast mitochondria with fatty acids and mitochondria-targeted lipophilic cations.
Sukhanova EI; Trendeleva TA; Zvyagilskaya RA
Biochemistry (Mosc); 2010 Feb; 75(2):139-44. PubMed ID: 20367600
[TBL] [Abstract][Full Text] [Related]
30. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells.
Modica-Napolitano JS; Aprille JR
Adv Drug Deliv Rev; 2001 Jul; 49(1-2):63-70. PubMed ID: 11377803
[TBL] [Abstract][Full Text] [Related]
31. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
32. Second generation, arginine-rich (R-X'-R)(4)-type cell-penetrating α-ω-α-peptides with constrained, chiral ω-amino acids (X') for enhanced cargo delivery into cells.
Patil KM; Naik RJ; Vij M; Yadav AK; Kumar VA; Ganguli M; Fernandes M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4198-202. PubMed ID: 25096299
[TBL] [Abstract][Full Text] [Related]
33. Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting.
Lin R; Zhang P; Cheetham AG; Walston J; Abadir P; Cui H
Bioconjug Chem; 2015 Jan; 26(1):71-7. PubMed ID: 25547808
[TBL] [Abstract][Full Text] [Related]
34. Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.
Verdurmen WP; Bovee-Geurts PH; Wadhwani P; Ulrich AS; Hällbrink M; van Kuppevelt TH; Brock R
Chem Biol; 2011 Aug; 18(8):1000-10. PubMed ID: 21867915
[TBL] [Abstract][Full Text] [Related]
35. Membrane permeable lipophilic cations as mitochondrial directing groups.
Madak JT; Neamati N
Curr Top Med Chem; 2015; 15(8):745-66. PubMed ID: 25732791
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of six-membered carbocyclic ring α,α-disubstituted amino acids and arginine-rich peptides to investigate the effect of ring size on the properties of the peptide.
Kato T; Kita Y; Iwanari K; Asano A; Oba M; Tanaka M; Doi M
Bioorg Med Chem; 2021 May; 38():116111. PubMed ID: 33838611
[TBL] [Abstract][Full Text] [Related]
37. Hybrid Cyclic-Linear Cell-Penetrating Peptides Containing Alternative Positively Charged and Hydrophobic Residues as Molecular Transporters.
Khayyatnejad Shoushtari S; Zoghebi K; Sajid MI; Tiwari RK; Parang K
Mol Pharm; 2021 Oct; 18(10):3909-3919. PubMed ID: 34491768
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
Young Kim H; Young Yum S; Jang G; Ahn DR
Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
[TBL] [Abstract][Full Text] [Related]
39. From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors.
Kurtoglu M; Lampidis TJ
Mol Nutr Food Res; 2009 Jan; 53(1):68-75. PubMed ID: 19072739
[TBL] [Abstract][Full Text] [Related]
40. Delivery of myo-Inositol Hexakisphosphate to the Cell Nucleus with a Proline-Based Cell-Penetrating Peptide.
Li M; Puschmann R; Herdlitschka A; Fiedler D; Wennemers H
Angew Chem Int Ed Engl; 2020 Sep; 59(36):15586-15589. PubMed ID: 32558101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
